John L. Villano, Md, Phd

This study tested a combination of two immunotherapy drugs (durvalumab and tremelimumab) in 14 adults with recurrent solid tumors that have a high number of genetic mutations. The goal was to see if this treatment could slow cancer growth longer than the patients' previous therap…

This study tested whether a short course of radiation to one tumor site could make immunotherapy work better in people with advanced lung or head/neck cancer. 76 participants received radiation within two weeks of starting their first immunotherapy dose. The main goal was to see …